Sumii, Toshihisa <br/><br/>
Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats.  [electronic resource] 

 -  Stroke  Mar 2002 
 - 831-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1524-4628 
<br/><br/><label>Standard No.: </label>10.1161/hs0302.104542  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Blood Flow Velocity--drug effects<br/>Brain--drug effects<br/>Brain Ischemia--etiology<br/>Cerebral Hemorrhage--etiology<br/>Cerebrovascular Circulation--drug effects<br/>Disease Models, Animal<br/>Enzyme Inhibitors--pharmacology<br/>Intracranial Embolism--complications<br/>Matrix Metalloproteinase 2--metabolism<br/>Matrix Metalloproteinase 9--metabolism<br/>Matrix Metalloproteinase Inhibitors<br/>Matrix Metalloproteinases--metabolism<br/>Phenylalanine--analogs & derivatives<br/>Rats<br/>Rats, Inbred SHR<br/>Sodium, Dietary<br/>Survival Rate<br/>Thiophenes--pharmacology<br/>Thrombolytic Therapy--adverse effects<br/>Tissue Plasminogen Activator--adverse effects